News summary

Wei Xinkangteenagemutantninjaturtlesarcadeattack: The subsidiary obtained the drug registration certificate for potassium aspartate injection securities times e company newsteenagemutantninjaturtlesarcadeattackWei Xinkang (603676) announced on the evening of May 5 that recently, Yangpu Jingtai Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received potassium aspartate injection approved and issued by the State Food and Drug Administrationteenagemutantninjaturtlesarcadeattack.teenagemutantninjaturtlesarcadeattack..

Newsletter text

Wei Xinkang: The subsidiary obtained the drug registration certificate for potassium aspartate injection. Securities Times e Company News, Wei Xinkang (603676) announced on the evening of May 5 that recently, Yangpu Jingtai Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the "Drug Registration Certificate" for potassium aspartate injection approved and issued by the State Food and Drug Administration. Potassium aspartate injection is an electrolyte supplement used for hypokalemia caused by various reasons.

(: Congratulations